Recently, a study revealed that NAFLD could promote CRC liver metastasis (CRLM) by promoting IL-1β and VEGF production from tumor-associated macrophages (TAMs) educated by the lipid-rich hepatic microenvironment [10]. This evidence concerns the gene IL1B and metabolic dysfunction-associated steatotic liver disease.